Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 13, 2015
Event: Entry into a Material Definitive Agreement regarding the amendment of an existing accounts receivable securitization program.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or general liquidity metrics. It specifically addresses a financing facility:
- Facility Type: Accounts Receivable Securitization Program (Receivables Facility).
- Maximum Borrowing Capacity: Up to $700 million outstanding from time to time, based on eligible receivables.
- Extension: The facility's scheduled termination date was extended to November 13, 2017.
- Lenders: A group of conduit lenders and liquidity banks including Crédit Agricole Corporate and Investment Bank (Administrative Agent), The Bank of Nova Scotia, and The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Material Changes Versus Prior Period
The primary material change is the execution of a Fifth Omnibus Amendment to the Receivables Facility originally dated March 21, 2012. Key changes include:
- Extension of the facility maturity date to November 13, 2017.
- Amendments to the Receivables Sale Agreement, Receivables Purchase and Contribution Agreement, and Receivables Loan Agreement.
- Continuation of the structure where subsidiaries sell healthcare accounts receivable (excluding self-pay) to a special purpose entity (CHS Receivables Funding, LLC) in exchange for cash and/or equity.
Guidance, Outlook, Risks, and Contingencies
Management Commentary: The filing confirms the intent for transactions to be treated as "true sales" or absolute contributions. CHS has guaranteed the performance of the Collection Agent but explicitly does not guarantee the collection of receivables resulting from the insolvency or bankruptcy of obligors.
Risks and Termination Events: The Loan Agreement contains customary termination events that could trigger early termination, including:
- Failure to make timely payments or deposits.
- Breach of covenants.
- Failure to make timely payments under other indebtedness.
- Certain changes of control.
- Failure to meet specific leverage ratios and Receivables ratios.
Unusual Items: None reported in this filing.
Investor Verification Checklist
- Verify the full text of the Fifth Omnibus Amendment (Exhibit 10.1) for specific covenant details and leverage ratio thresholds.
- Confirm the current utilization rate of the $700 million facility in subsequent quarterly reports (10-Q) or annual reports (10-K).
- Monitor compliance with the "Receivables ratios" and leverage covenants to assess the risk of early termination.
- Review the composition of eligible receivables to understand the asset quality backing the facility.